Science
Lucia Nappi: Presenting Final S1823 Results on miR371 in Early-Stage Testicular Cancer
Lucia Nappi/LinkedIn

Lucia Nappi: Presenting Final S1823 Results on miR371 in Early-Stage Testicular Cancer

Lucia Nappi, Medical Oncologist at BC Cancer, shared on LinkedIn:

“Excited to present the final results of S1823 clinical trial of miR371 in early stage testicular germ cell tumors in Madrid at ESMO 2026 annual meeting.

Read further here.”

You may also be interested in: Will Reeve and Testicular Cancer: Diagnosis, Surgery, Chemotherapy, and Recovery

Lucia Nappi: Presenting Final S1823 Results on miR371 in Early-Stage Testicular Cancer

BC Cancer cancer cancer care Cancer research Early-Stage Testicular Cancer esmo 2026 Lucia Nappi miR371 OncoDaily Oncology S1823 testicular cancer